bbin宝盈集团官网

Two-wheel drive with technological innovation and clinical value

Adhering to the dual drive of "technical innovation" and "clinical value", with the R&D and industrialization of "new markers/underlying technologies/key raw materials/automatic instruments" as the core, it is committed to treating malignant tumors, neurodegenerative diseases and major infectious diseases STD diagnosis offers innovative solutions!

Internationally leading, complete categories, covering the whole process of tumor diagnosis

The main product lines include molecular (PCR, NGS), protein (Elisa, chemiluminescence, POCT), exosome (mRNA, miRNA and protein)

Self-made key materials

High affinity recombinant antibodies, humanized or bispecific antibodies, eukaryotic antigens, traceable reference materials, engineered exosome standards, CTC standards, library building reagents, UMI linkers, key reaction enzymes, specific magnetic beads, Modified fillers, etc.

—— There is no "stuck neck" problem of raw materials suitable for industrialization, uncontrollable quality, high cost, long supply cycle and single source.

Talent is the core asset of Microdiag

Eclectic selection, employment and retention

Talent-oriented, focus on wisdom, inspire innovation, and dare to excel

Advance into the United States, realize the dual reporting of core products in China and the United States, and firmly practice "the world is true"

In 5 years, Microdiag entered the first-tier market in the United States and obtained original international recognition and interest premium.